Mucin armoured diethylaminoethyl-dextran cloaked rebamipide based oral nanoformulation for the therapy of inflammatory bowel disease
Chandrashekhar Jori, Anas Ahmad, Ajay Kumar, Nemat Ali, Young-Ok Son, Rehan Khan · 2026
Read Mucin armoured diethylaminoethyl-dextran cloaked rebamipide based oral nanoformulation for the therapy of inflammatory bowel disease by Chandrashekhar Jori, Anas Ahmad, Ajay Kumar, Nemat Ali, Young-Ok Son, Rehan Khan (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13276610.txt.
Description
Chandrashekhar Jori and colleagues build an oral nanoparticle treatment for inflammatory bowel disease in a 2026 study. Swallowed drugs often pass the gut too fast or break down in the stomach. Their carrier wraps the drug rebamipide in mucin and a sticky dextran layer, over an oil-based core.
The particles held together in stomach-like conditions regardless of acidity. They clung to the colon lining and stayed in the gut for up to two days. In treated animals, colon inflammation and several inflammatory markers fell more than with free rebamipide. The particles also raised mucin 2, a protective gut protein, which supported healing of the colon surface and its mucus-producing cells.
Catalog record
| CREATOR | Chandrashekhar Jori, Anas Ahmad, Ajay Kumar, Nemat Ali, Young-Ok Son, Rehan Khan |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 67 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |